文献速递妇科生殖医学

抗苗勒管激素作为多囊卵巢综合征及多囊卵巢形态诊断生物标志物:系统综述与Meta分析

Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis.
PubMed 文献 · Fertil Steril · 2024-06-27

本研究为2023年国际循证多囊卵巢综合征(PCOS)指南的一部分,系统评价抗苗勒管激素(AMH)水平用于诊断成人PCOS、青少年PCOS及成人多囊卵巢形态(PCOM)的准确性。纳入82项研究,成人AMH-PCOS的合并敏感度和特异度分别为0.79和0.87;青少年分别为0.66和0.78;成人AMH-PCOM分别为0.79和0.87。结论认为AMH单独不足以诊断PCOS,对青少年PCOM不具特异性,无法推荐国际统一截断值。

要点

  • 成人AMH诊断PCOS的合并敏感度0.79、特异度0.87(n=68项研究)。
  • 青少年AMH诊断PCOS的合并敏感度0.66、特异度0.78(n=11项研究)。
  • 成人AMH检测PCOM的合并敏感度0.79、特异度0.87(n=7项研究)。

核心结论

  • AMH水平单独不足以诊断PCOS,且对青少年PCOM不具特异性;无法推荐国际统一截断值,需研究更个体化的截断值。
  • 2023年国际循证PCOS指南推荐依据诊断算法采用AMH水平定义成人PCOM。

研究设计与样本

  • 系统综述与Meta分析,检索6个数据库至2023年7月31日,纳入82项报告敏感度、特异度和/或曲线下面积值的研究。
  • 采用诊断准确性研究质量评估工具评估偏倚风险,使用随机效应模型检验诊断准确性。

主要发现

  • 成人AMH-PCOS分析(n=68)合并敏感度0.79(95%CI 0.76-0.82;I²=86%),合并特异度0.87(95%CI 0.84-0.89;I²=91%)。
  • 青少年AMH-PCOS分析(n=11)合并敏感度0.66(95%CI 0.58-0.73;I²=74%),合并特异度0.78(95%CI 0.71-0.83;I²=45%)。
  • 成人AMH-PCOM分析(n=7)合并敏感度0.79(95%CI 0.72-0.85;I²=94%),合并特异度0.87(95%CI 0.78-0.93;I²=94%)。

关键数值与推荐

  • 成人AMH-PCOS:合并敏感度0.79(95%CI 0.76-0.82;I²=86%),合并特异度0.87(95%CI 0.84-0.89;I²=91%)。
  • 青少年AMH-PCOS:合并敏感度0.66(95%CI 0.58-0.73;I²=74%),合并特异度0.78(95%CI 0.71-0.83;I²=45%)。
  • 成人AMH-PCOM:合并敏感度0.79(95%CI 0.72-0.85;I²=94%),合并特异度0.87(95%CI 0.78-0.93;I²=94%)。

临床怎么用

  • 2023年国际循证PCOS指南推荐依据诊断算法采用AMH水平定义成人PCOM。
  • AMH水平单独不足以诊断PCOS,且对青少年PCOM不具特异性。
  • 无法推荐国际统一AMH截断值;作者强调需研究更个体化的截断值。

局限性

  • 多种因素影响AMH水平,导致本研究的异质性及局限性。
  • 成人AMH-PCOS分析异质性I²=86%(敏感度)和I²=91%(特异度)。
  • 青少年AMH-PCOS分析异质性I²=74%(敏感度)和I²=45%(特异度)。
  • 成人AMH-PCOM分析异质性I²=94%(敏感度和特异度)。
  • 无法推荐国际统一截断值,强调需研究更个体化的截断值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: As part of the 2023 international evidence-based polycystic ovary syndrome (PCOS) guideline, this meta-analysis investigated the inclusion of Anti-Müllerian hormone (AMH) levels in the diagnostic criteria for PCOS. OBJECTIVE: To answer the following three questions: 1) Are AMH levels effective in diagnosing PCOS in adult women? 2) Are AMH levels effective in diagnosing PCOS in adolescents? Are AMH levels effective in diagnosing polycystic ovarian morphology (PCOM)? DATA SOURCES: Searches were conducted in six databases until July 31, 2023. STUDY SELECTION AND SYNTHESIS: Eligible studies were those conducted in humans, published in English, and reporting sensitivity, specificity, and/or area under the curve values. Extracted data included study population, age, body mass index, AMH assay, cut-off value of AMH levels, sensitivity, specificity, and area under the curve values. The risk of bias was assessed using the quality assessment of diagnostic accuracy studies tool. A random effects model was used to test diagnostic accuracy. MAIN OUTCOMES: Pooled sensitivity and specificity to use AMH levels for PCOS diagnosis in adults as well as adolescents and for detecting PCOM in adults. RESULTS: Eighty-two studies were included. The adult AMH-PCOS meta-analyses (n = 68) showed a pooled sensitivity and specificity of 0.79 (95% confidence interval [CI], 0.76-0.82; I2 = 86%) and 0.87 (95% CI, 0.84-0.89; I2 = 91%). The adolescent AMH-PCOS meta-analysis (n = 11) showed a pooled sensitivity and specificity of 0.66 (95% CI, 0.58-0.73; I2 = 74%) and 0.78 (95% CI, 0.71-0.83; I2 = 45%). The adult AMH-PCOM meta-analysis (n = 7) showed a pooled sensitivity and specificity of 0.79 (95% CI, 0.72-0.85; I2 = 94%) and 0.87 (95% CI, 0.78-0.93; I2 = 94%). CONCLUSION AND RELEVANCE: This study investigated the most profound change in the 2023 international evidence-based PCOS guideline, which now recommends AMH levels for defining PCOM in adults in accordance with the diagnostic algorithm. Antimüllerian hormone levels alone are insufficient for PCOS diagnosis and are nonspecific for PCOM in adolescents. Multiple factors influence AMH levels and cause heterogeneity as well as limitations in this study. Consequently, no international cut-off value could be recommended, emphasizing the need for research on more individualized cut-off values.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. van der Ham K, Laven JSE, Tay CT, et al. Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis. Fertil Steril. 2024. PMID: 38944177. doi:10.1016/j.fertnstert.2024.05.163

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。